z-logo
open-access-imgOpen Access
Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does “X” Really Mark the Spot?
Author(s) -
Juliette K. Logan,
Robert J. Mentz
Publication year - 2019
Publication title -
current heart failure reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.036
H-Index - 39
eISSN - 1546-9549
pISSN - 1546-9530
DOI - 10.1007/s11897-019-00441-2
Subject(s) - medicine , biomarker , heart failure , ejection fraction , natriuretic peptide , brain natriuretic peptide , cardiology , intensive care medicine , cardiac surgery , clinical trial , guideline , randomized controlled trial , diastolic heart failure , pathology , biochemistry , chemistry
Explore controversial biomarker-guided management of patients with heart failure (HF) with reduced ejection fraction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here